Translating Tolerogenic Therapies to the Clinic - Where Do We Stand and What Are the Barriers?
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Mousavi S, Javadimoghadam M, Ghavamzadeh A, Alimoghaddam K, Sayarifard A, Ghaffari S Int J Hematol Oncol Stem Cell Res. 2017; 11(1):24-29.
PMID: 28286611 PMC: 5338278.
Tolerogenic Dendritic Cells on Transplantation: Immunotherapy Based on Second Signal Blockage.
Silva P, Bier J, Paiatto L, Galdino Albuquerque C, Souza C, Fernandes L J Immunol Res. 2015; 2015:856707.
PMID: 26543876 PMC: 4620289. DOI: 10.1155/2015/856707.
References
1.
Pasquet L, Joffre O, Santolaria T, van Meerwijk J
. Hematopoietic chimerism and transplantation tolerance: a role for regulatory T cells. Front Immunol. 2012; 2:80.
PMC: 3342389.
DOI: 10.3389/fimmu.2011.00080.
View
2.
Bruneau S, Woda C, Daly K, Boneschansker L, Jain N, Kochupurakkal N
. Key Features of the Intragraft Microenvironment that Determine Long-Term Survival Following Transplantation. Front Immunol. 2012; 3:54.
PMC: 3342046.
DOI: 10.3389/fimmu.2012.00054.
View
3.
Lutz M
. Therapeutic potential of semi-mature dendritic cells for tolerance induction. Front Immunol. 2012; 3:123.
PMC: 3355325.
DOI: 10.3389/fimmu.2012.00123.
View
4.
McGrath M, Najafian N
. The role of coinhibitory signaling pathways in transplantation and tolerance. Front Immunol. 2012; 3:47.
PMC: 3342378.
DOI: 10.3389/fimmu.2012.00047.
View
5.
Krummey S, Ford M
. Heterogeneity within T Cell Memory: Implications for Transplant Tolerance. Front Immunol. 2012; 3:36.
PMC: 3342058.
DOI: 10.3389/fimmu.2012.00036.
View